Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ned Sacktor

Showing results (101-110 of 141) with videos related to

Pageof 15
Sort By:
AIDS (London, England)|May 26, 2018
HIV disease and diabetes interact to affect brain white matter hyperintensities and cognitionMinjie Wu, Omalara Fatukasi, Shaolin Yang, et al.
AIDS (London, England)|February 1, 2019
Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effectsIgnacio Pérez-Valero, Ronald Ellis, Robert Heaton, et al.
Antiviral Therapy|March 27, 2015
Adiponectin and interleukin-6, but not adipose tissue, are associated with worse neurocognitive function in HIV-infected menJordan E Lake, Quynh T Vo, Lisa P Jacobson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 22, 2020
Neurocognitive Effects of Antiretroviral Initiation Among People Living With HIV in Rural UgandaAlyssa Vecchio, Kevin Robertson, Deanna Saylor, et al.
Neurology|June 16, 2019
Midlife adiposity predicts cognitive decline in the prospective Multicenter AIDS Cohort StudyLeah H Rubin, Deborah Gustafson, Kellie L Hawkins, et al.
Archives of Neurology|September 12, 2007
Platelet decline: an avenue for investigation into the pathogenesis of human immunodeficiency virus -associated dementiaLynn M Wachtman, Richard L Skolasky, Patrick M Tarwater, et al.
AIDS (London, England)|December 3, 2019
Presence of Tat and transactivation response element in spinal fluid despite antiretroviral therapyLisa J Henderson, Tory P Johnson, Bryan R Smith, et al.
Plos Clinical Trials|April 3, 2007
Factors in AIDS dementia complex trial design: results and lessons from the abacavir trialBruce J Brew, Mark Halman, Jose Catalan, et al.
Metabolic Brain Disease|February 12, 2014
HIV subtype is not associated with dementia among individuals with moderate and advanced immunosuppression in Kampala, UgandaNed Sacktor, Noeline Nakasujja, Andrew D Redd, et al.
Archives of Neurology|November 10, 2004
Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapyJustin C McArthur, Michael P McDermott, Daniel McClernon, et al.
Pageof 15

Showing results (101-110 of 141) with videos related to

Sort By:
Pageof 15
AIDS (London, England)|May 26, 2018
HIV disease and diabetes interact to affect brain white matter hyperintensities and cognitionMinjie Wu, Omalara Fatukasi, Shaolin Yang, et al.
AIDS (London, England)|February 1, 2019
Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effectsIgnacio Pérez-Valero, Ronald Ellis, Robert Heaton, et al.
Antiviral Therapy|March 27, 2015
Adiponectin and interleukin-6, but not adipose tissue, are associated with worse neurocognitive function in HIV-infected menJordan E Lake, Quynh T Vo, Lisa P Jacobson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 22, 2020
Neurocognitive Effects of Antiretroviral Initiation Among People Living With HIV in Rural UgandaAlyssa Vecchio, Kevin Robertson, Deanna Saylor, et al.
Neurology|June 16, 2019
Midlife adiposity predicts cognitive decline in the prospective Multicenter AIDS Cohort StudyLeah H Rubin, Deborah Gustafson, Kellie L Hawkins, et al.
Archives of Neurology|September 12, 2007
Platelet decline: an avenue for investigation into the pathogenesis of human immunodeficiency virus -associated dementiaLynn M Wachtman, Richard L Skolasky, Patrick M Tarwater, et al.
AIDS (London, England)|December 3, 2019
Presence of Tat and transactivation response element in spinal fluid despite antiretroviral therapyLisa J Henderson, Tory P Johnson, Bryan R Smith, et al.
Plos Clinical Trials|April 3, 2007
Factors in AIDS dementia complex trial design: results and lessons from the abacavir trialBruce J Brew, Mark Halman, Jose Catalan, et al.
Metabolic Brain Disease|February 12, 2014
HIV subtype is not associated with dementia among individuals with moderate and advanced immunosuppression in Kampala, UgandaNed Sacktor, Noeline Nakasujja, Andrew D Redd, et al.
Archives of Neurology|November 10, 2004
Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapyJustin C McArthur, Michael P McDermott, Daniel McClernon, et al.
Pageof 15